Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Non-Current Assets: 2015-2024

Historic Non-Current Assets for Editas Medicine (EDIT) over the last 10 years, with Dec 2024 value amounting to $52.3 million.

  • Editas Medicine's Non-Current Assets fell 55.94% to $24.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.9 million, marking a year-over-year decrease of 55.94%. This contributed to the annual value of $52.3 million for FY2024, which is 66.98% down from last year.
  • Latest data reveals that Editas Medicine reported Non-Current Assets of $52.3 million as of FY2024, which was down 66.98% from $158.3 million recorded in FY2023.
  • Over the past 5 years, Editas Medicine's Non-Current Assets peaked at $170.2 million during FY2021, and registered a low of $52.3 million during FY2024.
  • For the 3-year period, Editas Medicine's Non-Current Assets averaged around $122.7 million, with its median value being $157.6 million (2022).
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 240.83% in 2020, then plummeted by 66.98% in 2024.
  • Over the past 5 years, Editas Medicine's Non-Current Assets (Yearly) stood at $153.5 million in 2020, then rose by 10.85% to $170.2 million in 2021, then fell by 7.41% to $157.6 million in 2022, then rose by 0.48% to $158.3 million in 2023, then tumbled by 66.98% to $52.3 million in 2024.